Add Row
Add Element
Glytain Logo
update
Glytain.com
update
Add Element
  • Home
  • Categories
    • Healthcare
    • Innovation
    • Digital
    • Marketing
    • Analysis
    • Insights
    • Trends
    • Empowerment
    • Providers
    • Tech News
    • Extra News
Add Row
Add Element
February 26.2025
2 Minutes Read

Cedars-Sinai Uses Generative AI to Extract Data on Pickleball Injuries

Cedars-Sinai uses AI for pickleball injury data, two men playing.

Transforming Injury Data with AI

Cedars-Sinai Medical Center is leveraging the power of generative AI to analyze a growing concern: pickleball injuries. With the sport booming in popularity, injuries among players have surged, rising over 200% in recent years. Many of these injuries are attributed to falls, leading to serious conditions such as bone fractures and ligament sprains, as highlighted by a recent report.

Unleashing the Power of AI for Data Extraction

By harnessing AI, particularly the capabilities of GPT-4, Cedars-Sinai has been able to extract actionable data from unstructured medical notes. Kathy Bailey, a principal data intelligence analyst with the institution, emphasized that this innovative approach allows for the identification of injuries that traditional methods often miss. Previously, extracting this data required manual input from clerks, but AI enables a faster, more efficient review, cutting down the time from weeks or months to mere hours.

Significance of Accurate Data in Healthcare

The project not only showcases the advancements in healthcare technology but also addresses a critical gap in injury data collection. Given that many injuries occur outside of structured medical codes, having AI analyze clinician notes provides a richer depth of context surrounding each incident. This is especially pertinent in pickleball, where understanding the nuances can lead to better preventative strategies and patient outcomes.

Looking Ahead: The Future of Injury Prevention

As the popularity of pickleball continues on its exponential trajectory, insights gathered from this AI project could set a precedent for future studies in other sports. The findings not only shed light on pickleball injuries but could also contribute to shaping injury prevention strategies across various activities, particularly among older adults who are increasingly participating in these recreational sports.

As we embrace these technological advancements, the partnership between healthcare and AI stands to revolutionize how injury data is collected and analyzed, ultimately improving care for patients.

Kathy Bailey will present more on this innovative approach at HIMSS25, offering insights that could change the landscape of injury data collection in sports and healthcare.

Tech News

Write A Comment

*
*
Related Posts All Posts

Unleashing New Frontiers with Ready-to-Use Stem Cell Therapies for Pets

Update The Future of Veterinary Medicine: Stem Cells at the Forefront The world of veterinary medicine is on the cusp of a significant breakthrough with the potential introduction of ready-made stem cell therapies for pets, spearheaded by the San Diego startup, Gallant. Recently, Gallant announced it has secured $18 million in funding to initiate the journey towards the first FDA-approved ready-to-use stem cell therapy designed specifically for veterinary applications. If successful, this innovative approach could revolutionize how we treat various ailments in pets, providing veterinarians with new tools to enhance the quality of care. Current Research and Their Implications Historically, stem cell research has been prevalent in human medicine, with significant advancements occurring over the past several decades. However, veterinary applications have lagged behind, catching up only recently. Gallant’s initial focus is on treating Feline Chronic Gingivostomatitis (FCGS), a painful oral condition in cats, with hopes to obtain FDA approval by early 2026. Early studies with canines suffering from arthritis have yielded promising results, showcasing improvements in pain management and mobility that can persist for up to two years. However, other conditions, such as kidney disease in cats, have yielded mixed results, highlighting the need for further research and refinement. The Advantage of Ready-to-Use Solutions What sets Gallant apart from existing stem cell treatment options is the convenience factor. Traditional therapies often require the harvesting of stem cells from either the patient or a donor pet with matching tissues—a process that can be both time-consuming and ethically complex. In contrast, Gallant’s approach utilizes ready-to-use stem cells from donor animals, even across species barriers, which could streamline the process significantly. This not only enhances efficiency but also reduces the risks associated with manipulation of the patient's own cells. Investment and Market Potential Backed by strong investor confidence, Gallant has garnered a total of $44 million to date, with Digitalis Ventures leading the latest funding round. The growing interest from investors is indicative of the broader market potential for veterinary stem cell therapies. As innovative solutions, such as telemedicine and health tech gain momentum, such advancements at the intersection of veterinary medicine and biotechnology are increasingly vital. Conclusion As the veterinary field embraces technological advancements, the introduction of ready-to-use stem cell therapies from Gallant symbolizes a shift towards more progressive, accessible treatment options for pets. With continued research and positive outcomes, these therapies could not only change the lives of our furry friends but also shape the future landscape of animal healthcare.

Add Row
Add Element
Glytain Logo
update
WorldPulse News
cropper
update

Glytain empowers healthcare professionals and businesses to navigate the evolving digital landscape, driving innovation and improving patient outcomes. 🚀

  • update
  • update
  • update
  • update
  • update
  • update
  • update
Add Element

COMPANY

  • Privacy Policy
  • Terms of Use
  • Advertise
  • Contact Us
  • Menu 5
  • Menu 6
Add Element

+639220000000

AVAILABLE FROM 8AM - 5PM

City, State

, ,

Add Element

ABOUT US

At Glytain, we bridge the gap between healthcare and technology by delivering expert insights, cutting-edge trends, and in-depth analysis of digital health innovations. Our platform is designed for healthcare professionals, tech innovators, and forward-thinking businesses looking to stay ahead in the rapidly evolving healthcare landscape.

Add Element

© 2025 CompanyName All Rights Reserved. Address . Contact Us . Terms of Service . Privacy Policy

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*